Substance Use Disorders Edition 2
This CME meets the DEA-mandated eight hours of Medication Access and Training Expansion (MATE) Act.
Free for AAFP members
Read more about MATE: New DEA training requirement: who has to do it, and how to get it done.
More than 48 million Americans struggle with substance use disorder. Chances are, a portion of your patient base needs your help.
Learn the most up-to-date practices that help create a non-stigmatizing, trauma-informed approach to treatment and recovery. Put your learning to the test with new immersive technology that simulates a real patient interaction.
- Intake assessment and care coordination
- Trauma-informed care
- Interpreting toxicology reports
- Using buprenophine for OUD treatment
- Managing anxiety, depression and sleep issues
- Motivational interviewing
- Harm-reduction philosophy
More than 48 million Americans struggle with substance use disorder. Chances are, a portion of your patient base needs your help.
Learn the most up-to-date practices that help create a non-stigmatizing, trauma-informed approach to treatment and recovery. Put your learning to the test with new immersive technology that simulates a real patient interaction.
- Intake assessment and care coordination
- Trauma-informed care
- Interpreting toxicology reports
- Using buprenophine for OUD treatment
- Managing anxiety, depression and sleep issues
- Motivational interviewing
- Harm-reduction philosophy
Learning Objectives
Implement evidence-based guidelines and principles into the evaluation and treatment of patients with substance use disorders.
Demonstrate a patient-centered approach to the care of patients with substance use disorder with attention to destigmatizing language.
Discuss harm-reduction philosophy and approach to caring for patients and communities.
Demonstrate skills and techniques that are appropriate for use in patients with other substance use disorders.
Additional details
Alcohol Use Disorder: Screen, Diagnose, Treat and Support
Joyce Troxler, MD
Considering the Patient Perspective
Elizabeth Salisbury-Afshar, MD, MPH, FAAFP, DFASAM, FACPM; Brandon George
Emerging Psychoactive Substances: Fentanyl, Kratom and Xylazine
Jasleen Salwan, MD, MPH
Harm Reduction and Addressing Stigma
Elizabeth Salisbury-Afshar, MD, MPH, FAAFP, DFASAM, FACPM
Harm Reduction: Any Positive Change
Elizabeth Salisbury-Afshar, MD, MPH, FAAFP, DFASAM, FACPM
Intake Assessment and Care Coordination
David O’Gurek, MD
Interpretation of Toxicology Results
Anika Alvanzo, MD, MS, DFASAM, FACP
Managing Common Comorbidities: Sleep, Anxiety and Depression
Sky Lee, MD, AAHIVS
Principles of Motivational Interviewing
David O’Gurek, MD
Smoking Cessation and E-Cigarettes
Marie-Elizabeth Ramas, MD, FAAFP
Stimulant Use Disorder: The Tools in Our Toolbox
Hannah Snyder, MD
Substance Use Disorders Edition 2 Reflection and Translation to Practice® (t2p®)
David O’Gurek, MD
The Evidence Base for Treatment of OUD
Elizabeth Salisbury-Afshar, MD, MPH, FAAFP, DFASAM, FACPM
The Impact of Drug Policy on SUDs
Elizabeth Salisbury-Afshar, MD, MPH, FAAFP, DFASAM, FACPM; David O’Gurek, MD; Jason Glenn, PhD
Trauma-informed Care
David O’Gurek, MD
Treatment of OUD with Buprenorphine Part 1: Initiation of Treatment
Nicole Gastala, MD
Treatment of OUD With Buprenorphine Part 2: Follow-up Visits and Maintenance
Margaret Lowenstein, MD, M. Phil., MSHP
What Is Addiction?
Elizabeth Salisbury-Afshar, MD, MPH, FAAFP, DFASAM, FACPM
*Enhance your patient care today and earn up to two additional AAFP Prescribed credits for when you complete the Translation to Practice® (t2p®) process.
David O’Gurek, MD—Course director
Speakers:
- Anika Alvanzo, MD, MS, DFASAM, FACP
- Brandon George
- David O’Gurek, MD—Course director
- Elizabeth Salisbury-Afshar, MD, MPH, FAAFP, DFASAM, FACPM
- Hannah Snyder, MD
- Jasleen Salwan, MD, MPH
- Jason Glenn, PhD
- Joyce Troxler, MD
- Margaret Lowenstein, MD, M.Phil., MSHP
- Marie-Elizabeth Ramas, MD, FAAFP
- Nicole Gastala, MD
- Sky Lee, MD, AAHIVS
CME credit statement
People with substance use disorder do not receive the treatment they need.